WMSA
PTX

Weiss Multi-Strategy Advisers’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,115
Closed -$104K – 1217
2013
Q4 		$104K Buy
+4,115
New +$98K ﹤0.01% 943

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SC
Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
EWP
Edmunds White Partners Richmond, Virginia $69.2M AUM 56.3% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PTX Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2014, closing a stake of 4,115 shares — an estimated $104K sold.

Weiss Multi-Strategy Advisers first reported a position in PTX in Q4 2013 and held it in 1 quarter. The position peaked at $104K in Q4 2013. 63 funds tracked by Wall St. Rank hold PTX as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 4,115 Pernix Therapeutics Holdings, Inc. shares in Q1 2014, an estimated $104K.
  • Weiss Multi-Strategy Advisers first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Pernix Therapeutics Holdings, Inc. position peaked at $104K in Q4 2013.
  • 63 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.